Anyone here following CLBE's tech, or are most just here watching the TA?
I'm optimistic that the huge volume of corporate investment we are seeing into RNAi companies like ALNY, ISIS, Tacere will trickle down to KD Medical and Molecula. Their products were designed for this emerging market.
Hopefully, all the unsuing clinical and lab research will drive revenues. It's got to be a race, now with many of the large pharma corps in, maybe we won't have a long wait.